Education
About Us
Working with TipRanks
Follow Us
Andrew Aromando Insider Profile
4 Followers
Andrew Aromando, COO at Ambrx Biopharma, holds 55.10K shares in Oncolytics Biotech (Ticker: ONCY), holds 109.26K shares in Ambrx Biopharma (Ticker: AMAM). Most recently, Andrew Aromando Bought ― shares of Oncolytics Biotech on Feb 13, 2026 for an estimated value of $25.16K.
Andrew Aromando Ambrx Biopharma (AMAM)COO
Ambrx Biopharma (AMAM)
COO
Not Ranked
Andrew Aromando has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Andrew Aromando's holdings
Insider Roles
Chief Business Officer
Roles that Andrew Aromando holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Andrew Aromando
Andrew Aromando's Trading History
Ambrx Biopharma
Dec 11, 2023
―
Uninformative Buy
―
$3.06M
Oncolytics Biotech
Feb 13, 2026
Chief Business Officer
Informative Buy
25.16K
$56.20K
List of latest transactions for each holding click on a transaction to see Andrew Aromando's performance on stock
You May Also Like
Andrew Aromando insider profile FAQ
What is the percentage of profitable transactions made by Andrew Aromando?
The percentage of profitable transactions made by Andrew Aromando is ―.
What is the average return per transaction made by Andrew Aromando?
The average return per transaction made by Andrew Aromando is ―.
What stocks does Andrew Aromando hold?
Andrew Aromando holds: AMAM, ONCY stocks.
What was Andrew Aromando’s latest transaction?
Andrew Aromando latest transaction was an Informative Buy of $25.16K.
What was Andrew Aromando's most profitable transaction?
Andrew Aromando’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Andrew Aromando's role in Ambrx Biopharma?
Andrew Aromando's role in Ambrx Biopharma is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.